Silence Therapeutics (SLN)

NASDAQ: SLN · Real-Time Price · USD

4.20

0.19 (4.74%)

At close: May 02, 2025, 12:07 PM

Silence Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-45.31M	-50.31M	-47.37M	-45.86M	-36.04M	-22.87M	-20.53M	-3.77M	-10.36M
Depreciation & Amortization	336K	498K	482K	427K	496K	482K	399K	433K	310K
Stock-Based Compensation	16.31M	13.05M	10.25M	8.63M	4.39M	584K	681K	638K	475K
Other Working Capital	-32.12M	-11.98M	-7.68M	11.36M	47.96M	21.09M	-924K	n/a	n/a
Other Non-Cash Items	-5.95M	9.07M	-559K	347K	-4.67M	136K	-45K	-206K	-1.54M
Deferred Income Tax	n/a	n/a	n/a	4.41M	6.39M	2.31M	1.82M	-8.4M	1.59M
Change in Working Capital	-33.02M	-11.66M	-8.26M	38.84M	18.66M	21.09M	913K	1.71M	-539K
Operating Cash Flow	-67.64M	-39.35M	-45.46M	6.81M	-10.78M	1.73M	-16.76M	-9.6M	-10.07M
Capital Expenditures	-211K	-45K	-440K	-1.33M	-514K	-9K	-188K	-173K	-537K
Cash Acquisitions	n/a	n/a	n/a	-10M	40.72M	n/a	-58K	-13.22M	n/a
Purchase of Investments	-139.17M	-20.67M	-16.13M	10M	-40.04M	-15M	-5M	-4.92M	-4.3M
Sales Maturities Of Investments	n/a	36.18M	n/a	10M	10M	n/a	319K	18.12M	n/a
Other Investing Acitivies	117.41M	958K	23K	10K	-541K	-6K	97K	13.2M	161K
Investing Cash Flow	-21.97M	16.43M	-16.54M	8.68M	9.62M	-15.02M	-4.83M	13.01M	-4.67M
Debt Repayment	n/a	-174K	-190K	-211K	-402K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-101K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	142.09M	n/a	43.24M	30.92M	15.83M	n/a	n/a	n/a	-101K
Financial Cash Flow	142.09M	25.16M	43.05M	30.71M	15.43M	5.27M	341K	48K	-101K
Net Cash Flow	52.54M	-785K	-18.72M	46.09M	13.93M	-7.98M	-21.25M	3.73M	-12.89M
Free Cash Flow	-67.85M	-39.4M	-45.9M	5.47M	-11.29M	1.72M	-16.95M	-9.77M	-10.6M